Literature DB >> 2463651

The NK-3 tachykinin agonist senktide elicits yawning and chewing mouth movements following subcutaneous administration in the rat. Evidence for cholinergic mediation.

A J Stoessl1, C T Dourish, S D Iversen.   

Abstract

The selective NK-3 tachykinin receptor agonist senktide elicited yawning, chewing mouth movements and sexual arousal following subcutaneous administration (0.1-1.0 mg/kg) in the rat. These responses were not significantly affected by the dopamine antagonist haloperidol (0.03 mg/kg) or by 6-hydroxydopamine lesions of the nigrostriatal projection. In contrast, the behaviours were markedly attenuated by the peripheral and central muscarinic antagonist scopolamine (1 mg/kg), but not by the peripheral muscarinic antagonist N-methylscopolamine (1 mg/kg). These findings suggest that stimulation of NK-3 receptors produces yawning, chewing and sexual arousal by directly activating central cholinergic neurons.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2463651     DOI: 10.1007/bf00172963

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  34 in total

1.  Behavioural changes in animals after intracisternal injection with adrenocorticotrophic hormone and melanocyte-stimulating hormone.

Authors:  W FERRARI
Journal:  Nature       Date:  1958-03-29       Impact factor: 49.962

2.  Drugs affecting dopamine neurons and yawning behavior.

Authors:  E Mogilnicka; V Klimek
Journal:  Pharmacol Biochem Behav       Date:  1977-10       Impact factor: 3.533

3.  Senktide, a selective neurokinin B-like agonist, elicits serotonin-mediated behaviour following intracisternal administration in the mouse.

Authors:  A J Stoessl; C T Dourish; S C Young; B J Williams; S D Iversen; L L Iversen
Journal:  Neurosci Lett       Date:  1987-10-05       Impact factor: 3.046

4.  Behavioural and pharmacological characterization of the mouth movements induced by muscarinic agonists in the rat.

Authors:  J D Salamone; M D Lalies; S L Channell; S D Iversen
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Effects of apomorphine, TL-99 and 3-PPP on yawning in rats.

Authors:  E Mogilnicka; C G Boissard; A Delini-Stula
Journal:  Neuropharmacology       Date:  1984-01       Impact factor: 5.250

6.  Permissive role of D-1 receptor stimulation by endogenous dopamine for the expression of postsynaptic D-2-mediated behavioural responses. Yawning in rats.

Authors:  R Longoni; L Spina; G Di Chiara
Journal:  Eur J Pharmacol       Date:  1987-02-10       Impact factor: 4.432

7.  Yawning is elicited by D2 dopamine agonists but is blocked by the D1 antagonist, SCH 23390.

Authors:  G Serra; M Collu; G L Gessa
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

8.  Apomorphine-induced penile erection and yawning: site of action in brain.

Authors:  M R Melis; A Argiolas; G L Gessa
Journal:  Brain Res       Date:  1987-07-07       Impact factor: 3.252

9.  Relation between yawning behavior and central serotonergic neuronal system in rats.

Authors:  S Okuyama; H Shimamura; S Hashimoto; H Aihara
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-06       Impact factor: 3.000

10.  Yawning elicited by systemic and intrastriatal injection of piribedil and apomorphine in the rat.

Authors:  C T Dourish; S J Cooper; S R Philips
Journal:  Psychopharmacology (Berl)       Date:  1985       Impact factor: 4.530

View more
  2 in total

1.  Yawning induced by apomorphine, physostigmine or pilocarpine is potentiated by dihydropyridine calcium channel blockers.

Authors:  A Bourson; P C Moser
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

2.  Comparative behavioural profile of centrally administered tachykinin NK1, NK2 and NK3 receptor agonists in the guinea-pig.

Authors:  O Piot; J Betschart; I Grall; S Ravard; C Garret; J C Blanchard
Journal:  Br J Pharmacol       Date:  1995-11       Impact factor: 8.739

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.